Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
X4 Pharmaceuticals, Inc | Chief Commercial Officer | Common Stock | 48.5K | $28.4K | $0.58 | Oct 7, 2024 | Direct |
X4 Pharmaceuticals, Inc | Chief Commercial Officer | Stock Appreciation Right | 523K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals, Inc | Oct 4, 2024 | 2 | -$6.51K | 4 | Oct 8, 2024 | Chief Commercial Officer |
XFOR | X4 Pharmaceuticals, Inc | Feb 13, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Chief Commercial Officer |
XFOR | X4 Pharmaceuticals, Inc | Nov 1, 2023 | 1 | -$7.49K | 4 | Nov 3, 2023 | Chief Commercial Officer |
XFOR | X4 Pharmaceuticals, Inc | Oct 31, 2023 | 1 | $0 | 4 | Nov 2, 2023 | Chief Commercial Officer |
XFOR | X4 Pharmaceuticals, Inc | Nov 3, 2022 | 1 | $644K | 4 | Nov 4, 2022 | Chief Commercial Officer |
XFOR | X4 Pharmaceuticals, Inc | Nov 3, 2022 | 0 | $0 | 3 | Nov 4, 2022 | Chief Commercial Officer |